NO972726L - Tricykliske forbindelser - Google Patents

Tricykliske forbindelser

Info

Publication number
NO972726L
NO972726L NO972726A NO972726A NO972726L NO 972726 L NO972726 L NO 972726L NO 972726 A NO972726 A NO 972726A NO 972726 A NO972726 A NO 972726A NO 972726 L NO972726 L NO 972726L
Authority
NO
Norway
Prior art keywords
tricyclic compounds
stands
hydrogen
remedy
tricyclic
Prior art date
Application number
NO972726A
Other languages
English (en)
Norwegian (no)
Other versions
NO972726D0 (no
Inventor
Makoto Yoshida
Shin-Ichi Sasaki
Shigeru Aono
Shigeki Fujiwara
Haruki Takai
Tsuyoshi Yamagata
Ken Nagashima
Akira Karasawa
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of NO972726D0 publication Critical patent/NO972726D0/no
Publication of NO972726L publication Critical patent/NO972726L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/16—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/06—Ring systems of three rings
    • C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D313/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/78—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings
    • C07D333/80—Seven-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02—Seven-membered rings
    • C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/12—[b,e]-condensed
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/30—Ortho- or ortho- and peri-condensed systems containing three rings containing seven-membered rings
    • C07C2603/32—Dibenzocycloheptenes; Hydrogenated dibenzocycloheptenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Surgical Instruments (AREA)
  • Eye Examination Apparatus (AREA)
  • Led Devices (AREA)
  • Dental Preparations (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
NO972726A 1995-10-16 1997-06-13 Tricykliske forbindelser NO972726L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP26723295 1995-10-16
JP32429895 1995-12-13
PCT/JP1996/002997 WO1997014672A1 (en) 1995-10-16 1996-10-16 Triciclic compounds

Publications (2)

Publication Number Publication Date
NO972726D0 NO972726D0 (no) 1997-06-13
NO972726L true NO972726L (no) 1997-08-05

Family

ID=26547771

Family Applications (1)

Application Number Title Priority Date Filing Date
NO972726A NO972726L (no) 1995-10-16 1997-06-13 Tricykliske forbindelser

Country Status (12)

Country Link
US (1) US5726325A (de)
EP (1) EP0798288B1 (de)
JP (1) JP3847786B2 (de)
CN (1) CN1168133A (de)
AT (1) ATE201195T1 (de)
AU (1) AU700386B2 (de)
DE (1) DE69612835T2 (de)
ES (1) ES2159047T3 (de)
HU (1) HUP9801356A3 (de)
NO (1) NO972726L (de)
NZ (1) NZ320580A (de)
WO (1) WO1997014672A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5840749A (en) * 1989-08-25 1998-11-24 Hoechst Marion Roussel, Inc. N-hydroxy-dibenz b,e!oxepinalkylamines, N-hydroxy-dibenz b,e!oxepinalkanoic acid amides and related heterocyclic analogues
EP0842179A1 (de) * 1995-07-24 1998-05-20 Takeda Chemical Industries, Ltd. Verfahren zur herstellung von optisch aktivenbezothiepin salzen
BR9808552A (pt) * 1997-04-15 2000-05-23 Kyowa Hakko Kogyo Kk Composto tricìclico ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
DE60036758T2 (de) 1999-08-04 2008-07-24 Sumitomo Chemical Co., Ltd. Verfahren zur Herstellung von optisch aktiver 3,3,3-Trifluor-2-hydroxy-2-methylpropionsäure und deren Salze
BR0208420A (pt) * 2001-03-30 2004-03-30 Kyowa Hakko Kogyo Kk Agente terapêutico para bexiga hiperativa, uso do composto tricìclico ou do sal farmaceuticamente aceitável do mesmo, e, método para o tratamento de bexiga hiperativa
CA2442472A1 (en) * 2001-03-30 2002-10-10 Kyowa Hakko Kogyo Co., Ltd. Therapeutic agent for bladder irritative symptoms associated with benign prostatic hyperplasia
EA007069B1 (ru) * 2001-03-30 2006-06-30 Киова Хакко Когио Ко., Лтд. Терапевтическое средство по поводу повышенной чувствительности мочевого пузыря
EP1444980A1 (de) * 2001-11-13 2004-08-11 Kyowa Hakko Kogyo Co., Ltd. Mittel zur prävention oder behandlung von pruritus
TW200400816A (en) * 2002-06-26 2004-01-16 Lilly Co Eli Tricyclic steroid hormone nuclear receptor modulators
JPWO2004087131A1 (ja) * 2003-03-31 2006-06-29 協和醗酵工業株式会社 鎮咳剤
TW200501938A (en) * 2003-06-27 2005-01-16 Kyowa Hakko Kogyo Kk A medicament for therapeutic treating overactive urinary bladder accompany with cerebrovascular disorder
WO2005007154A1 (ja) * 2003-07-16 2005-01-27 Kyowa Hakko Kogyo Co., Ltd. 疼痛の予防及び／または治療剤
WO2005011674A1 (ja) * 2003-08-05 2005-02-10 Kyowa Hakko Kogyo Co., Ltd. 気管支喘息の予防及び／または治療剤
FR2872159B1 (fr) * 2004-06-28 2007-10-05 Merck Sante Soc Par Actions Si Nouveaux derives acides carboxyliques phenyliques et leur utilisation dans le traitement du diabete
TW200606133A (en) * 2004-06-30 2006-02-16 Sankyo Co Substituted benzene compounds
DE102005022020A1 (de) * 2005-05-12 2006-11-23 Merckle Gmbh Dibenzocycloheptanverbindungen und pharmazeutische Mittel, welche diese Verbindungen enthalten
US7550478B2 (en) * 2005-06-23 2009-06-23 Merck & Co. Inc. Tyrosine kinase inhibitors
JP2009512707A (ja) * 2005-10-21 2009-03-26 メルク エンド カムパニー インコーポレーテッド チロシンキナーゼインヒビター
JP2009513580A (ja) * 2005-10-21 2009-04-02 メルク エンド カムパニー インコーポレーテッド チロシンキナーゼ阻害剤
US7790739B2 (en) * 2005-10-21 2010-09-07 Merck & Co., Inc. and Merck Sharp & Dohme Corp. Tyrosine kinase inhibitors
TW200813021A (en) * 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
TW200827367A (en) * 2006-10-26 2008-07-01 Kyowa Hakko Kogyo Kk A therapeutic agent for irritable bowel syndrome
CN111885914B (zh) * 2017-10-27 2022-05-13 投资健康有限责任公司 使用芴衍生物制造扩增的造血干细胞的组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458578A (en) * 1965-03-22 1969-07-29 Sandoz Ag Aminodibenzocycloalkenones
US4477465A (en) * 1983-03-10 1984-10-16 Hoechst-Roussel Pharmaceuticals Inc. Substituted 4,10-dihydro-10-oxothieno benzoxepins
JPS6310784A (ja) * 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9214120D0 (en) * 1991-07-25 1992-08-12 Ici Plc Therapeutic amides

Also Published As

Publication number Publication date
ES2159047T3 (es) 2001-09-16
JP3847786B2 (ja) 2006-11-22
AU700386B2 (en) 1999-01-07
WO1997014672A1 (en) 1997-04-24
NO972726D0 (no) 1997-06-13
HUP9801356A3 (en) 2000-07-28
CN1168133A (zh) 1997-12-17
ATE201195T1 (de) 2001-06-15
EP0798288B1 (de) 2001-05-16
DE69612835T2 (de) 2001-10-04
HUP9801356A2 (hu) 1998-10-28
EP0798288A1 (de) 1997-10-01
MX9704411A (es) 1998-07-31
DE69612835D1 (de) 2001-06-21
US5726325A (en) 1998-03-10
NZ320580A (en) 1998-12-23
EP0798288A4 (de) 1999-06-16
AU7332696A (en) 1997-05-07

Similar Documents

Publication Publication Date Title
NO953305L (no) Antranilsyrederivat
ZA9610315B (en) Naphthyl-substituted benzimidazole derivates as anti-coagulants
AU9264398A (en) Method for producing (hetero)aromatic hydroxylamines
CO5031285A1 (es) Triarilimidazoles
NO972726D0 (no) Tricykliske forbindelser
ATE191218T1 (de) Rapamycin-derivate als immunosuppressoren
NO944252L (no) Heterocykliske forbindelser, deres fremstilling og anvendelse
EP1527049B8 (de) Kondensierte heterozyklische verbindungen als petidase inhibitoren
NO992821L (no) Ketobenzamider som calpain-inhibitorer
WO2003014110A1 (en) Benzazepine derivative, process for producing the same, and use
EP1172361A4 (de) Sulfonamidderivate mit oxadiazolringen
NO981393L (no) Guanidinoproteasehemmere
EP1043312A4 (de) Heterocyclische verbindungen die nos-hemmende aktivitäten besitzen
MX9701949A (es) Derivados de distamicina substituidos con bis-(2-haloetil) aminofenilo como agentes antitumorales y antivirales.
MX9700179A (es) Derivados de triazol y su utilizacion.
DE69915471D1 (de) Analoga von distamycin-zimtsäurederivaten, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
DK0737187T3 (da) Benzoxazinderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som lægemidler
CA2419463A1 (en) Primary intermediates for oxidative coloration of hair
DK0788472T3 (da) Fremgangsmåde til fremstilling af 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalenderivater
TW200504159A (en) Monoazo compound and process for making same
ES8506662A1 (es) Procedimiento para la preparacion de derivados de naftaleniltiazol
CO4940468A1 (es) Nuevos derivados de naftilpiperacina
NO974870L (no) Nye substituerte tetrahydropyrano £3,2-d|- oxazoloner, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem
GR3020125T3 (en) Carbostyril derivatives.
CA2172946A1 (en) N-(.alpha.-alkylbenzylidene)-.alpha.-phenylalkylamine, its use and process for producing the same and process for producing intermediate

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application